Sinus, cold, and allergy remedies comprise the most widely used sector of the over-the-counter (OTC) drug market. Direct-to-consumer advertising (DTCA) of pharmaceutical products has increased over the past 30 years, including the promotion of OTC drugs. The influence of DTCA on OTC sinonasal remedies comprises several positive and negative effects. Favorable aspects of this influence include empowerment and promotion of autonomy among patients, avoidance of low-value clinical encounters, self-directed education, and decreased healthcare expenditures. This is balanced by potential concerns, including the lack of rigorous regulation of OTC drugs, the burden of self-diagnosis, the risk of unsupervised use resulting in adverse effects or drug interactions, and redistribution of pharmacy costs to the consumer. Despite the proliferation of product options and consumer-directed information, healthcare utilization and cost of treating sinonasal disease remains high. Moreover, the availability of OTC sinonasal remedies and exposure to DTCA has had mixed effects without apparent overall benefit to patient and consumer health. Laryngoscope, 130:2114-2119, 2020.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/lary.28366 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patient-reported outcome measures for acute rhinosinusitis in adults and children: a systematic review of the quality of existing instruments.
Health Qual Life Outcomes
September 2024
Institute of Social Medicine and Health Systems Research, Medical Faculty, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, Magdeburg, 39120, Germany.
Background: Acute rhinosinusitis (ARS) is a self-limiting inflammation of the nose and sinuses caused by viral or bacterial infections that requires primarily symptomatic treatment. Patient-reported outcome measures (PROMs) are suitable tools for the assessment of the effectiveness of remedies for ARS from the patient's perspective in clinical trials and real-world studies. Data regarding the quality of existing PROMs for ARS are limited.
View Article and Find Full Text PDFContemporary Role and Regulation of Over-the-Counter Sinonasal Medications.
Otolaryngol Head Neck Surg
July 2021
Department of Otorhinolaryngology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA.
Objective: Numerous pharmaceutical options are available over-the-counter (OTC) for the relief of sinonasal symptoms. Patients typically utilize these drugs in an unsupervised manner, without appreciation of their relative efficacy or potential for adverse effects. This review covers the scope and regulation of the OTC drug market, the pros and cons of OTC availability, and specific concerns that surround the most common classes of OTC sinonasal drugs.
View Article and Find Full Text PDFAssessment of Pharmacologic Ingredients in Common Over-the-Counter Sinonasal Medications.
JAMA Otolaryngol Head Neck Surg
September 2020
Department of Otorhinolaryngology, Ochsner Clinic Foundation, New Orleans, Louisiana.
Importance: Sinonasal remedies are the most frequently purchased category of over-the-counter (OTC) drugs in the United States. A variety of options for relief are available under proprietary names, although the actual number of available options may not be readily appreciated by the consumer or the clinician.
Objective: To determine the prevalence of specific ingredients in OTC sinonasal products.
Direct-To-Consumer Advertising of Over-the-Counter Sinonasal Remedies: A History of Mixed Messages.
Laryngoscope
September 2020
Department of Otorhinolaryngology, Ochsner Clinic Foundation, New Orleans, Louisiana, U.S.A.
Sinus, cold, and allergy remedies comprise the most widely used sector of the over-the-counter (OTC) drug market. Direct-to-consumer advertising (DTCA) of pharmaceutical products has increased over the past 30 years, including the promotion of OTC drugs. The influence of DTCA on OTC sinonasal remedies comprises several positive and negative effects.
View Article and Find Full Text PDFHead and Neck Squamous Cell Carcinoma in Western Uganda: Disease of Uncertainty and Poor Prognosis.
OTO Open
March 2018
Dental and Oral Surgery Department, Mbarara University of Science and Technology, Mbarara, Uganda.
Objectives: Patients with head and neck squamous cell carcinoma (HNSCC) have symptoms that masquerade as benign conditions, resulting in late presentations. The objective is to describe characteristics and stages of patients with HNSCC and document their prognosis from clinical experience in western Uganda.
Study Design: Cross-sectional study with clinical follow-up.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!